We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$157M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$112M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$109M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$73.1M
5
T icon
AT&T
T
+$64.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$73.7M
3
DD icon
DuPont de Nemours
DD
+$64.2M
4
CCI icon
Crown Castle
CCI
+$45.2M
5
CSCO icon
Cisco
CSCO
+$42M

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QHC
3526
DELISTED
Quorum Health Corporation
QHC
$19K ﹤0.01%
+13,762
New +$22.6K
ASCMA
3527
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$17K ﹤0.01%
+16,041
New +$14.6K
SBUX icon
3528
CALL
Starbucks
SBUX
$120B
$16K ﹤0.01%
10,100
-3,300
-25% -$259K
XELB icon
3529
Xcel Brands
XELB
$6.6M
$16K ﹤0.01%
+1,100
New +$15K
DGSE
3530
DELISTED
DGSE Companies, Inc.
DGSE
$16K ﹤0.01%
+12,274
New +$7.88K
SDR
3531
DELISTED
SANDRIDGE MISSISSIPPIAN TRUST II
SDR
$16K ﹤0.01%
25,883
+850
+3% +$725
SNAP icon
3532
CALL
Snap
SNAP
$9.01B
$15K ﹤0.01%
+22,800
New +$279K
IDXG
3533
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$15K ﹤0.01%
2,000
– –
BABA icon
3534
CALL
Alibaba
BABA
$308B
$14K ﹤0.01%
23,600
+400
+2% +$69K
CCJ icon
3535
CALL
Cameco
CCJ
$42.4B
$14K ﹤0.01%
12,000
– –
NEOS
3536
DELISTED
Neos Therapeutics, Inc
NEOS
$14K ﹤0.01%
+10,500
New +$19.3K
LCTX icon
3537
Lineage Cell Therapeutics
LCTX
$278M
$13K ﹤0.01%
12,213
+39
+0.3% +$45
NFLX icon
3538
CALL
Netflix
NFLX
$309B
$13K ﹤0.01%
127,000
+19,000
+18% +$685K
TYME
3539
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$13K ﹤0.01%
+10,912
New +$15.3K
CCL icon
3540
CALL
Carnival Corporation Ltd
CCL
$39.7B
$12K ﹤0.01%
120,800
-55,600
-32% -$2.91M
CTXR icon
3541
Citius Pharmaceuticals
CTXR
$18.7M
$12K ﹤0.01%
480
– –
ZION icon
3542
CALL
Zions Bancorporation
ZION
$10.3B
$12K ﹤0.01%
12,700
-400
-3% -$18.5K
CBL
3543
DELISTED
CBL& Associates Properties, Inc.
CBL
$12K ﹤0.01%
11,194
-2,659
-19% -$3.07K
CMCSA icon
3544
CALL
Comcast
CMCSA
$90B
$11K ﹤0.01%
47,300
+2,500
+6% +$105K
CRM icon
3545
CALL
Salesforce
CRM
$158B
$11K ﹤0.01%
21,000
+10,000
+91% +$1.57M
MTNB icon
3546
Matinas BioPharma
MTNB
$1.81M
$11K ﹤0.01%
+250
New +$12K
USMV icon
3547
PUT
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$11K ﹤0.01%
+30,900
New +$1.86M
WHWK
3548
Whitehawk Therapeutics
WHWK
$271M
$11K ﹤0.01%
800
-1,267
-61% -$19.2K
CBRE icon
3549
CALL
CBRE Group
CBRE
$42.9B
$10K ﹤0.01%
12,000
+500
+4% +$24.8K
SNGX icon
3550
Soligenix
SNGX
$5.81M
$10K ﹤0.01%
61
– –
140 141
142
143 144

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.